N.V. NUTRICIA;ROBERT JOHAN JOSEPH HAGEMAN;PATRICK JOSEPH GERADUS HENDRIKUS KAMPHUIS;LADISLAUS MARIA BROERSEN
发明人:
ROBERT JOHAN JOSEPH HAGEMAN,PATRICK JOSEPH GERADUS HENDRIKUS KAMPHUIS,LADISLAUS MARIA BROERSEN
申请号：
IL20296709
公开号：
IL202967A
申请日:
2009.12.24
申请国别(地区):
IL
年份:
2012
代理人:
摘要：
A composition comprising (a) one or more É-3 fatty acids selected from DHA, DPA and EPA, (b) uridine or its equivalent, and (c) a methyl donor, useful in the treatment of a person having characteristics of a prodromal dementia patient. The characteristics include e.g. a level of more than 350 ng Total-tau per litre cerebrospinal fluid (CSF), and a weight ratio of abeta-42/ Phospho-tau-181 of less than 6.5 in CSF.
